Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial

Abstract Background For patients with pancreatic ductal adenocarcinoma (PDAC), surgical resection remains the only potentially curative treatment. Surgery is generally followed by postoperative chemotherapy associated with improved survival, yet neoadjuvant therapy is a rapidly emerging concept requ...

Повний опис

Бібліографічні деталі

Автори:	Christelle Bouchart, Julie Navez, Ivan Borbath, Karen Geboes, Timon Vandamme, Jean Closset, Luigi Moretti, Pieter Demetter, Marianne Paesmans, Jean-Luc Van Laethem
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2023-09-01
Серія:	BMC Cancer
Предмети:	Pancreatic adenocarcinoma FOLFIRINOX Stereotactic body radiation Borderline resectable Chemotherapy Neoadjuvant therapy
Онлайн доступ:	https://doi.org/10.1186/s12885-023-11327-x
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!